PsiloThera Announces Launch of Quantum Technology Drug Development Program

PsiloThera Inc. launched a quantum technology drug development program that could change the way we digest supplements, medications and nutrients.

PsiloThera’s CEO claims that the program could significantly reduce drug development time and costs, and could improve dispensing issues and adverse effects of pharmaceuticals. The technology could also lead to advancements in energy-based nutrients and medication delivery systems. The company is focusing on treatments for depression, anxiety, PTSD, eating disorders, addiction, dementia, and autism (to name a few), and is currently crowdsourcing funds through a Start Engine campaign.